Work

P2X7 as Common Therapeutic Target in Brain Diseases

Year: 2021

Type: other

Source: MPG.PuRe (Max Planck Society)

Authors: Engel, T., Nicke, A., Deussing, J. ; https://orcid.org/0000-0002-9329-5252, Sperlagh, B., Diaz-Hernandez, M.

Institutions: Royal College of Surgeons in Ireland, Science Foundation Ireland, Walther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Max Planck Institute of Psychiatry, HUN-REN Institute of Experimental Medicine, Universidad Complutense de Madrid

Language: English

Topic: Adenosine and Purinergic Signaling

Subfield: Physiology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: European Commission

Award: Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases.

OpenAlex ID: W7155660673

Cites: 10

Cited by:

Related to: 10